MPARX

Maine Pharmacy Association

DHHS shared guidance documents for e-prescribing and opioid dispensing

DHHS shared guidance documents for e-prescribing and opioid dispensing.  Notably, “A pharmacist is NOT required to verify that a practitioner has a waiver of the requirement to electronically prescribe…” To review the official documents, please click on the links below. Electronic-Prescribing-Clarifications Opioid Dispensing Clarification    

E-Prescribing Grace Period Notice and Chapter 488 User Guide

The deadline for mandatory e-prescribing of opioids was rapidly approaching on July 1st. However, the State sent the following communication announcing a 31 day grace period for enforcement of the penalties for violating the e-prescribing provision.  This is good news and will give prescribers and dispensers a little more time to prepare. DHHS provided material on other provisions in Chapter […]

2017 Scholarship Golf Scramble

Join us for our 2017 Scholarship Golf Scramble ! Where: Val Halla Country Club When: Saturday, August 12, 2017 Shotgun start 1pm Includes 18 holes of golf on a championship course, golf cart, BBQ dinner at Rachel’s on the Green! Cost: Single Golfer: $110.00 Foursome: $400.00 Dinner Only: $35.00 Corporate or personal hole sponsorship: $75 […]

Pharmacists from across Maine convene in Augusta to advocate for profession and patients

Pharmacists and pharmacy students from across the state convened in Augusta on May 30th to advocate for LD 572.   Update: Senate passes LD 572; now on to the House!  LD 572 specifies in statute that the “Practice of Pharmacy” is “the provision of health care services” and that “Pharmacists” are “providers of health care services”. […]

LD6 and LD44 Are Successfully Moving Through the Legislative Process

Good news!!  Two bills, LD 6, an “An Act to Prohibit Insurance Carriers from Retroactively Reducing Payment on Clean Claims Submitted by Pharmacies” and LD 455, “An Act Relating to the Provision of Smoking Cessation Services by Pharmacists” are moving through the legislature process. LD 6, an “An Act to Prohibit Insurance Carriers from Retroactively Reducing Payment on […]

Archive for October, 2013

*********************************************************************************

April 2017

MPA One Day CE Program

Continuing Education

April 1, 2017

Husson University

Bangor, ME

Information will be provided as it is finalized.

*********************************************************************************

October 2017

MPA Sesquicentennial

Celebrating 150 years of the first professional state pharmacy association!

October 13th -15th, 2017

Holiday Inn By the Bay

Portland, ME

 

Dear Colleagues and Friends in Pharmacy,

I want to provide a quick update regarding our lawsuit against the Maine prescription importation law.  On September 10th, the Plaintiffs (MPA et al.) filed suit in the United States District Court for the District of Maine challenging the legality of a pharmaceutical importation ordinance that was passed by the Maine Legislature earlier this year.  As expected, the State Defendants filed a motion to dismiss our case on October 2nd.  On October 16th, we filed our opposition to the Defendants’ motion to dismiss and we also filed our reply to the Defendants’ opposition to our motion for preliminary injunction.  On October 30th, the Defendants filed their reply in support of their motion to dismiss our case.
Which brings us to the present, where both sides of the case have filed all necessary briefs.  Meanwhile, MaineMeds, PortlandMeds, and  HardwoodMeds have reinstated their Rx drug importation programs.  We’ve also recently answered interview questions from radio, newspaper and television journalists from as far away as California about the consequences of this law.  It’s apparent that both healthcare professionals and lawmakers in many states are closely monitoring this law and our lawsuit. The next step in this legal process will involve oral arguments which will likely be heard by Judge Nancy Torresen in the next few weeks.  All of the court documents can be found in their entirety at the links above.  Furthermore, MPA’s key concerns with Maine’s prescription drug importation law can be found here.  We’ll continue to keep you up-to-date as this case moves forward.

MPA provides professional strength through association.
MPA is working for you!
Membership matters for you and for your profession!
Invest in your future with Maine Pharmacy Association.
Join MPA today!

Sincerely,

Kenneth L. McCall, BSPharm, PharmD
President | Maine Pharmacy Association

American Pharmacists Month

KNOW YOUR MEDICINE; KNOW YOUR PHARMACIST.

  • Pharmacists help ensure the safe use of medications for every patient
  • Pharmacist provide preventative health care services including immunizations
  • Studies have found that people who regularly meet with their pharmacist to manage their medications have
    • Lower healthcare costs
    • Fewer trips to the emergency department
    • Fewer hospital visits
    • Better medication outcomes
    • Better understanding of their medications
    • Better understanding of chronic disease states
  • Pharmacists are your neighborhood health expert
    • From Fort Kent to Kittery Maine, pharmacists are the most accessible healthcare professionals
  • Pharmacists are consistently ranked in national Gallop polls as one of the most trusted professions
  • Pharmacists must complete a minimum of six years of college education and advanced training to become medication and wellness experts

Southern California Public Radio recently interviewed Representative Sharon Treat and MPA President Kenneth McCall regarding Maine’s new law to allow prescription drug imports.  Listen to the full interview here:

http://www.scpr.org/programs/airtalk/2013/10/11/34129/maine-becomes-first-state-in-nation-to-allow-presc/

CanaRx added to list of “Not Recommended Sites” by the National Association of Board of Pharmacy.  According to NABP, ordering drugs from CanaRx and other sites on this list “puts you and your family at risk.”  NABP recommends that patients use a licensed pharmacy including sites accredited through the VIPPS program.

http://www.nabp.net/programs/consumer-protection/buying-medicine-online/not-recommended-sites

Dear Pharmacy Colleagues,

Several new laws were passed during Maine’s 126th legislative session that will impact pharmacy.  These new laws take effect October 9th, 2013.  Here’s a summary of the new legislation with a link to each law.

An Act to Amend the Laws Governing Pharmacy Interns

This law allows a pharmacy intern, who has received training and who is under the direct supervision of a pharmacist, to administer vaccines to persons 18 or older.

An Act to Expand the Types of Vaccines that May be Administered by Pharmacists

Expands the law that allows pharmacists to administer vaccines that are outside the guidelines recommended by the CDC to adults according to a valid prescription when the practitioner states that the vaccine is medically necessary.  For example, a pharmacist may administer the zoster vaccine to a 40-year-old patient (even though the vaccine is recommended by the CDC for adults 60 years and older) if the practitioner authorizes a valid prescription and states that the vaccine is medically necessary.

An Act Regarding Pharmacy Provider Audits

This law adds provisions in current laws relating to on-site audits of pharmacy providers conducted by PBMs: requires 10 days written notice of audits and range of prescription numbers and dates to be included in the audit, includes right to request mediation by a private mediator with mutual agreement, and makes clear that the provisions relating to retrospective denial of claims apply to pharmacy claims subject to an audit.

An Act to Allow Collaborative Practice Agreements Between Authorized Practitioners and Pharmacists

This law defines Collaborative Drug Therapy Management and Collaborative Practice Agreement in the Maine Pharmacy Act.  The law expands the “practice of pharmacy” in Maine to include CDTM.  A pharmacist with training may initiate, monitor, modify and discontinue a patient’s drug therapy as authorized by a practitioner in accordance with a written collaborative practice agreement.  The Board of Pharmacy and Board of Medicine shall adopt rules to implement this new law.

MPA provides professional strength through association.
MPA is working for you!

Membership matters for you and for your profession!

Invest in your future with Maine Pharmacy Association.

Join MPA today!

http://www.mparx.com/membership/

Sincerely,

Kenneth L. McCall, BSPharm, PharmD

President | Maine Pharmacy Association

Dear Colleagues and Friends in Pharmacy,

I want to provide a quick update regarding our lawsuit against the Maine prescription importation law.  As expected, Attorney General Janet Mills filed a motion to dismiss the complaint by Maine Pharmacy Association et al regarding the lawsuit in the United States District Court for the District of Maine challenging the legality of a prescription drug importation ordinance that was passed by the Maine legislature earlier this year.

Of note, one of the primarily arguments in the motion to dismiss is “…the 2013 Amendment [prescription drug importation law] does not affirmatively ‘authorize’ any person, whether located in Maine or elsewhere, to do anything.”  Also noteworthy, the motion to dismiss acknowledges that “…no Secretary of HHS has issued a certification [to Congress that importation will be safe and cost-effective].”  The plaintiffs including Maine Pharmacy Association have 21 days to respond and we are confident that our case has merit.  The entire motion to dismiss is available on the MPA website:

http://www.mparx.com/wp-content/uploads/2013/10/2013-Defendants-Motion-to-Dismiss.pdf

MPA provides professional strength through association.

MPA is working for you!

Membership matters for you and for your profession!

Invest in your future with Maine Pharmacy Association.

Join MPA today!

http://www.mparx.com/membership/

Sincerely,

Kenneth L. McCall, BSPharm, PharmD

President | Maine Pharmacy Association